Medsamic

Tranexamic Acid, the active ingredient in Medsamic, is an antifibrinolytic presented as an injection solution for intravenous use. It treats excessive bleeding such as menorrhagia, trauma‑related bleeding, surgical bleeding, and is used for hereditary angioedema prophylaxis.

GNH USA supplies Medsamic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tranexamic Acid is used to control bleeding in conditions where fibrinolysis is excessive.

Menorrhagia: reduces menstrual blood loss in women with heavy periods. Trauma-related bleeding: helps control hemorrhage following traumatic injury. Surgical bleeding: minimizes intra‑operative and post‑operative blood loss. Hereditary angioedema prophylaxis: prevents attacks by stabilizing plasma clots.

Tranexamic Acid may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea or vomiting - Diarrhea or abdominal discomfort - Headache or dizziness - Injection site pain or erythema - Mild hypotension - Transient visual disturbances

Serious or Rare Side Effects: - Thromboembolic events (deep vein thrombosis, pulmonary embolism) - Seizures, especially with high doses or renal impairment - Severe allergic reactions (anaphylaxis, angioedema) - Acute renal failure or worsening of existing renal disease - Cardiovascular collapse or severe hypotension - Vision loss or retinal artery occlusion

Before using Medsamic, clinicians should evaluate patient‑specific risk factors and monitor for complications.

Assess renal function: adjust use in patients with severe renal impairment. Monitor for thrombotic risk: avoid in patients with active thrombosis or high clotting risk. Avoid in disseminated intravascular coagulation: contraindicated in DIC. Review concomitant anticoagulants: evaluate bleeding risk when combined. Pregnancy and lactation: use only if benefits outweigh potential risks (category unknown). Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Tranexamic Acid can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Procoagulant agents (e.g., activated factor VII) may increase thrombosis risk. - Hormonal contraceptives may augment clot formation. - Other antifibrinolytics (e.g., aprotinin) may cause excessive clotting.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin, heparin) may have reduced efficacy. - Antiplatelet drugs (aspirin, clopidogrel) may increase bleeding tendency. - Nephrotoxic agents (aminoglycosides) may worsen renal function when combined.